Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178646 · ClinicalTrials.gov registry record · Phase 4
Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity
A Phase 4 study of Stroke and Brain Injuries, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 4
- Development phase
- 33
- Enrollment target
- 2
- Study locations
NCT00178646 is a Phase 4 study of Stroke and Brain Injuries that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 33 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00178646, a Phase 4 study of Stroke and Brain Injuries, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 33 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study seeks to compare the effectiveness of three preparations of BOTOX-A® in treating muscle tightness and spasms in the feet and ankles of people with stroke.
Conditions Studied
Interventions
- DRUG Botox
Study Locations (2)
New Jersey
- Kessler Institute for Rehabiliation - West Orange
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2002-01 |
| Est. Completion | 2010-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178646
The ClinicalTrials.gov registry entry for NCT00178646 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Botox is the first listed.
NCT00178646 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Texas.
Frequently Asked Questions
What is clinical trial NCT00178646 about?
NCT00178646 is a clinical study titled "Comparative Efficacy of Three Preparations of Botox-A in Treating Spasticity". The study seeks to compare the effectiveness of three preparations of BOTOX-A® in treating muscle tightness and spasms in the feet and ankles of people with stroke.
What is the current status of trial NCT00178646?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 33 participants. The study started on 2002-01. Estimated completion is 2010-03.
What conditions does trial NCT00178646 study?
This clinical trial studies the following conditions: Stroke, Brain Injuries, Spasticity.
What interventions are being tested in trial NCT00178646?
The interventions under investigation include: Botox (DRUG).
Who is sponsoring clinical trial NCT00178646?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178646 being conducted?
This trial has 2 study locations across New Jersey, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
International Care Bundle Evaluation in Cerebral Hemorrhage Research
RECRUITING · Phase 4
-
Xeomin® and Gait Related Mobility After Stroke
RECRUITING · Phase 4
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
RECRUITING · Phase 4
-
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction
ACTIVE NOT RECRUITING · Phase 4
-
SEdation Versus General Anesthesia for Endovascular Therapy in Acute Ischemic Stroke
COMPLETED · Phase 4
-
Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.